It acts through the GLP-1 receptor (GLP-1R), a G protein-coupled receptor (GPCR) predominantly expressed in pancreatic -cells, the gastrointestinal tract, and the central nervous system
This nucleus is the first stop for all the signals coming from the gastrointestinal tract via the vagus nerve, and its directly connected to many other brain areas controlling feeding
2,8 With increasing evidence, additional roles are being proposed
This limits the affordability of many patients, especially from low- and middle-income groups and those who do not have medical insurance, restricting market growth
Individuals taking GLP-1 receptor agonists should still prioritize protein and fiber intake to maintain muscle mass during weight loss and support long-term metabolic health
GLP-1 Receptor Agonist Market Trends Expansion of Oral GLP-1 Receptor Agonist Therapies Beyond Injectable Formulations The market is witnessing a transition from injectable-only treatment approaches toward oral GLP-1 receptor agonist therapies, improving patient convenience and treatment adherence
